These findings support that SMYD3 plays a critical role in CRC carcinogenesis, promoter hypomethylation may be a mechanism for SMYD3 upregulation, and that SMYD3 confers lower a survival rate and poor prognosis in this disease. The gene discussed is SMYD3; the disease is colorectal carcinoma.